Shanghai United Imaging Healthcare (688271)
Recommendation: Technical Buy
Last Price: 136.80
Bullish Reversal Incoming
Technical Analysis:
- Entry Prices: 136.80, 120.00, 100.74
- Support Levels: 119.66, 100.74
- Stop Loss: 100.50
- Resistance Levels: 158.86, 199.93
- Target Prices: 159.15, 190.40, 210.05, 240.50
Shanghai United Imaging Healthcare Co., Ltd. is known for developing, manufacturing, and distributing medical imaging systems and equipment. This includes products such as computed tomography scanners, mobile medical devices, molecular imaging instruments, and magnetic resonance equipment. Additionally, the company offers equipment leasing services.
Key Insights:
- The stock has broken out of the downtrend line that started in October 2022.
- Despite a heavy correction on October 8, 2024, the stock managed to rebound and close higher above the resistance turned support at RMB 119.66.
- The larger bullish divergence confirms the bullish reversal.
- Volume has been expanding steadily for the past 32 daily periods.
- Prices are trending above all Ichimoku indicators.
- The stochastic oscillator has been rising, confirming the bullish momentum.
- The MACD/signal line has risen after the crossover at the bottom occurred, with the histogram remaining positive.
- The 23-period ROC is rising and has rebounded above the zero line.
Given these indicators, Shanghai United Imaging Healthcare is showing strong potential for a bullish reversal, making it a promising buy opportunity at the current prices.
Seatrium Ltd (SIN)
Recommendation: Maintain Add
Target Price: S\$2.69
Execution is Still Key
Key Insights:
- Estimated EPC contract value of US\$400m-500m by 1Q25 for the Penta Ocean heavy lift vessel, for which STM has secured a Letter of Intent (LOI) for engineering work.
- In its 3Q24 business update, STM shared that the pipeline and enquiries are healthy for 2024/2025, including FPSOs, rigs, and energy transition projects.
- Legacy projects are still on track for end 2024/early 2025 delivery.
- STM is not adversely worried about potential uptick in cost overruns.
Seatrium Ltd continues to demonstrate strong execution capabilities, with a robust pipeline of projects and healthy enquiries for the coming years. The company remains confident in its ability to manage cost overruns and deliver on legacy projects within the expected timeline. The conclusion of CAD/MAS document investigation, sequential margin improvement, and order wins are viewed as key catalysts for the stock.
WHA Corporation (THB)
3Q24 Misses on FX Loss and Expenses
WHA Corporation faced challenges in the third quarter of 2024 due to foreign exchange losses and increased expenses. These factors contributed to the company’s performance missing expectations for the period. Investors should monitor how the company addresses these issues in the upcoming quarters.
Sunway Bhd (MAL)
Expect Strong 3Q to Pave Way for Upgrades
Sunway Bhd is anticipated to report strong results for the third quarter of 2024, which could lead to potential upgrades. The company’s robust performance is expected to be driven by its diversified business operations and strategic investments. Investors should keep an eye on the upcoming earnings report for further insights.
Praram 9 Hospital (THB)
Boosted by Foreign Patient Traffic
Praram 9 Hospital has seen a boost in its performance due to increased foreign patient traffic. This trend highlights the hospital’s growing reputation and appeal to international patients. The influx of foreign patients is expected to positively impact the hospital’s revenue and overall financial health.
